The function and usability of two hybrid closed loop systems in patients aged 13 - 25 years with type 1 diabetes during a 7 day hotel study.
Not Applicable
Not yet recruiting
- Conditions
- Type 1 diabetes
- Registration Number
- ACTRN12617001294347
- Lead Sponsor
- princess Margaret Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of hybrid closed loop systems in managing type 1 diabetes in adolescents and young adults?
How does the performance of hybrid closed loop systems compare to standard insulin pump therapy in type 1 diabetes patients aged 13-25?
What biomarkers are associated with optimal glycemic control using hybrid closed loop systems in type 1 diabetes?
What adverse events are reported with hybrid closed loop systems in outpatient type 1 diabetes management?
How do different hybrid closed loop systems impact patient adherence and quality of life in type 1 diabetes management?